How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?

Nadine Norton, Edith A. Perez

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Clinical outcome of patients with breast cancer is based on patient and tumor-related factors. The relevant tumor-related factors include anatomical extent and biology. Of the prognostic and predictive biological markers available, hormone receptors (defined as estrogen and progesterone receptors) and HER2 receptors, have been independently validated. Pertinent questions to be addressed include their combined impact on prognosis, their relevance in terms of sites of metastases, and whether they change in primary versus recurrent tumors. Although these questions are being addressed in clinical trials, epidemiological results, such as those derived from the National Comprehensive Cancer Network dataset, add perspective to our understanding of these two most relevant biological prognostic/predictive markers.

Original languageEnglish (US)
Article number101
JournalBreast Cancer Research
Volume15
Issue number1
DOIs
StatePublished - Jan 14 2013

Fingerprint

Hormones
Breast Neoplasms
Neoplasms
Progesterone Receptors
Estrogen Receptors
Biomarkers
Clinical Trials
Neoplasm Metastasis
Datasets

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer? / Norton, Nadine; Perez, Edith A.

In: Breast Cancer Research, Vol. 15, No. 1, 101, 14.01.2013.

Research output: Contribution to journalArticle

@article{50dfee3bbcb7450d83212b223cd82927,
title = "How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?",
abstract = "Clinical outcome of patients with breast cancer is based on patient and tumor-related factors. The relevant tumor-related factors include anatomical extent and biology. Of the prognostic and predictive biological markers available, hormone receptors (defined as estrogen and progesterone receptors) and HER2 receptors, have been independently validated. Pertinent questions to be addressed include their combined impact on prognosis, their relevance in terms of sites of metastases, and whether they change in primary versus recurrent tumors. Although these questions are being addressed in clinical trials, epidemiological results, such as those derived from the National Comprehensive Cancer Network dataset, add perspective to our understanding of these two most relevant biological prognostic/predictive markers.",
author = "Nadine Norton and Perez, {Edith A.}",
year = "2013",
month = "1",
day = "14",
doi = "10.1186/bcr3335",
language = "English (US)",
volume = "15",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?

AU - Norton, Nadine

AU - Perez, Edith A.

PY - 2013/1/14

Y1 - 2013/1/14

N2 - Clinical outcome of patients with breast cancer is based on patient and tumor-related factors. The relevant tumor-related factors include anatomical extent and biology. Of the prognostic and predictive biological markers available, hormone receptors (defined as estrogen and progesterone receptors) and HER2 receptors, have been independently validated. Pertinent questions to be addressed include their combined impact on prognosis, their relevance in terms of sites of metastases, and whether they change in primary versus recurrent tumors. Although these questions are being addressed in clinical trials, epidemiological results, such as those derived from the National Comprehensive Cancer Network dataset, add perspective to our understanding of these two most relevant biological prognostic/predictive markers.

AB - Clinical outcome of patients with breast cancer is based on patient and tumor-related factors. The relevant tumor-related factors include anatomical extent and biology. Of the prognostic and predictive biological markers available, hormone receptors (defined as estrogen and progesterone receptors) and HER2 receptors, have been independently validated. Pertinent questions to be addressed include their combined impact on prognosis, their relevance in terms of sites of metastases, and whether they change in primary versus recurrent tumors. Although these questions are being addressed in clinical trials, epidemiological results, such as those derived from the National Comprehensive Cancer Network dataset, add perspective to our understanding of these two most relevant biological prognostic/predictive markers.

UR - http://www.scopus.com/inward/record.url?scp=84872382810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872382810&partnerID=8YFLogxK

U2 - 10.1186/bcr3335

DO - 10.1186/bcr3335

M3 - Article

C2 - 23316883

AN - SCOPUS:84872382810

VL - 15

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 1

M1 - 101

ER -